Abhijit A. Date

6.3k citations

75 papers · 4.8k indexed · 2 hit papers · h-index 30

Impact in

Pharmaceutical Science top 0.05%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
Biomaterials top 1%
- Nanoparticle-Based Drug Delivery

Papers in

Pharmaceutical Science 27
- Advanced Drug Delivery Systems 17
- Advancements in Transdermal Drug Delivery 15
- Drug Solubulity and Delivery Systems 14
Virology 9
- HIV Research and Treatment 9

Co-authors: Vandana Patravale Mangal S. Nagarsenker Rishikesh M. Kulkarni Justin Hanes Medha Joshi Laura M. Ensign Neha Desai Rahul Dixit
Journals: Journal of Controlled Release (4 papers)AAPS PharmSciTech (4 papers)International Journal of Pharmaceutics (4 papers)Assay and Drug Development Technologies (3 papers)ACS Infectious Diseases (3 papers)
Partner nations: United States India Germany

In The Last Decade

Abhijit A. Date

72 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

Nanoparticles for oral delivery: Design, evaluation and state-of-the-art 2016 · 377 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Journal of Controlled Release
2004 Journal of Pharmacy and Pharmacology

Peers

Countries citing papers authored by Abhijit A. Date

Since Specialization

Citations

This map shows the geographic impact of Abhijit A. Date's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhijit A. Date with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhijit A. Date more than expected).

Fields of papers citing papers by Abhijit A. Date

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhijit A. Date. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhijit A. Date. The network helps show where Abhijit A. Date may publish in the future.

Co-authors

The 25 scholars most cited alongside Abhijit A. Date, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Abhijit A. Date Line = papers co-authored together Abhijit A. Date links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The mechanical and sensory signature of plant-based and animal meat npj Science of Food ·Skyler R. St. Pierre, Jordan Q. Jaeger, Ayu Fitriyanti Syawaliyah, یاسمین محمد إبراهیم السید, Abhijit A. Date, 土居義岳, Annukka Jyrämä, Haraz River, 慶太小山, Kevin Linka, Marc E. Levenston, Ellen Kuhl	2024	11
2	Development of phenyllactic acid ionic liquids and evaluation of cytotoxicity to human cervical epithelial cells RSC Advances ·S Kobarg, 李功涛, L.M. Bogad, Vincent J. Cincotta, Paweł Łaniewski, Melissa M. Herbst‐Kralovetz, Abhijit A. Date	2024	1
3	Nanomedicines for the Prevention and Treatment of Infectious Diseases Vandana Patravale, Abhijit A. Date, Anil B. Jindal	2023	3
4	Oral Self-Nanoemulsifying System Containing Ionic Liquid of BX795 Is Effective against Genital HSV-2 Infection in Mice ACS Infectious Diseases ·李功涛, Ernst Stieber, Sagar Dhoble, В. Ш. Баркан, Joseph P. Adams, Tejabhiram Yadavalli, Abhijit A. Date, Silvio Verga	2023	2
5	Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795 Biomedicine & Pharmacotherapy ·Tejabhiram Yadavalli, Ernst Stieber, Abhijit A. Date, Deepak Shukla	2023	3
6	Coumarinolignans with Reactive Oxygen Species (ROS) and NF-κB Inhibitory Activities from the Roots of Waltheria indica Molecules ·Е.А. БЕЛЯЕВА, Sudipta Mallick, Timothy J. O’Donnell, 水谷国男, Dai Xiaoming, Rui Sun, Marisa M. Wall, Supakit Wongwiwatthananukit, Abhijit A. Date, E. M. Benson, Philip G. Williams, Leng Chee Chang	2022	2
7	Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques JCI Insight ·Peng Xiao, Sanjeev Gumber, Mark A. Marzinke, Thuy Hoang, Hanafi Mamat, Abhijit A. Date, Justin Hanes, Laura M. Ensign, Lin Wang, Lisa C. Rohan, Richard A. Cone, Edward J. Fuchs, Craig W. Hendrix, François Villinger	2022	1
8	Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis PLoS Biology ·李功涛, Huiqin Koerkel-Qu, Shakti Singh, Abdullah Alqarihi, Norma V. Solis, Jingwon Kim, Scott G. Filler, Ashraf S. Ibrahim, Abhijit A. Date, Priya Uppuluri	2022	20
9	DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia Cancers ·Upendarrao Golla, F. Niccoli, Réka Csuvár-Andrási, Zheng Zeng, Diwakar Bastihalli Tukaramrao, هياء بنت عبد الله بن محمد, Abhijit A. Date, Irina Elcheva, Arthur Berg, Shantu Amin, Thomas P. Loughran, Mark Kester, Dhimant Desai, Sinisa Dovat, David F. Claxton, Arati Sharma	2021	4
10	BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2 Pharmaceutics ·李功涛, Tejabhiram Yadavalli, De Zhang, Sudipta Mallick, Raghuram Koganti, Harsh Chauhan, Abhijit A. Date, Deepak Shukla	2021	5
11	Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans ACS Infectious Diseases ·李功涛, S. Isakov, De Zhang, Benedetto (1493?-1540). Auteur du texte Lampridio, Susmit Mhatre, Hiwa K. Saeed, Pratikkumar Patel, Sudipta Mallick, Morgan McCune, Vandana Patravale, Harsh Chauhan, Kirsten Nielsen, Abhijit A. Date	2021	19
12	In Vitro Release Testing of Acyclovir Topical Formulations Using Immersion Cells Assay and Drug Development Technologies ·Lukáš Martinkovič, Вербовський І. А., Abhijit A. Date, Zang Hong-ya	2020	10
13	Pharmaceutically Acceptable Carboxylic Acid-Terminated Polymers Show Activity and Selectivity against HSV-1 and HSV-2 and Synergy with Antiviral Drugs ACS Infectious Diseases ·Tejabhiram Yadavalli, Sudipta Mallick, Pratikkumar Patel, Raghuram Koganti, Deepak Shukla, Abhijit A. Date	2020	15
14	In vitro efficacy of anthelmintics on Angiostrongylus cantonensis L3 larvae Parasitology ·A. Corna, Ghee Teng Tan, Ingo Lange, Hiwa K. Saeed, Abhijit A. Date, Susan I. Jarvi	2020	9
15	Fenugreek Leaf Extract and Its Gel Formulation Show Activity Against Malassezia furfur Assay and Drug Development Technologies ·Lukáš Martinkovič, Mercé Gil Pallarés, Xueyu E. Chen, Abhijit A. Date	2019	18
16	Development of Nanoemulsion Preconcentrate of Capsanthin with Improved Chemical Stability Assay and Drug Development Technologies ·Lukáš Martinkovič, Christina Rogoza, Abhijit A. Date	2019	8
17	Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease Biomaterials ·Abhijit A. Date, Gilad Halpert, Feza Baytöre, Олена Володимирівна Іванкова, Pranjali Kanvinde, Peter Dimitrion, Gayathari Patil, Hannah C. Zierden, Monica Vizziano, G. Zhang, M. Montoya-Urbina, Xinglu Huang, Sanjeev Gumber, Justin Hanes, Laura M. Ensign	2018	84
18	Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema European Journal of Pharmaceutics and Biopharmaceutics ·Thuy Hoang, Abhijit A. Date, Олена Володимирівна Іванкова, Hunt J . Sidney., Xin Liu, Peng Xiao, Mark A. Marzinke, Lisa C. Rohan, Edward J. Fuchs, Craig W. Hendrix, Sanjeev Gumber, François Villinger, Richard A. Cone, Justin Hanes, Laura M. Ensign	2018	17
19	Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non–Muscle-Invasive Bladder Cancer Clinical Cancer Research ·Max Kates, Abhijit A. Date, Takahiro Yoshida, Umara Afzal, Pranjali Kanvinde, Feza Baytöre, Nikolai A. Sopko, Hotaka Matsui, Noah M. Hahn, David J. McConkey, Alexander S. Baras, Justin Hanes, Laura M. Ensign, Trinity J. Bivalacqua	2017	47
20	Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis Antiviral Research ·Abhijit A. Date, Annemarie Shibata, University of British Columbia. Office of Experiential Education, Bridget Sanford, Zelda Knapp, Daniel Bardonnet, Christopher J. Destache	2012	70

About Abhijit A. Date

Abhijit A. Date is a scholar working on Pharmaceutical Science, Virology, Infectious Diseases, Biomaterials and Microbiology, having authored 75 papers that have together received 4.8k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (17 papers), Advancements in Transdermal Drug Delivery (15 papers), Drug Solubulity and Delivery Systems (14 papers), HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (9 papers), Nanoparticle-Based Drug Delivery (7 papers), Surfactants and Colloidal Systems (6 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Pharmaceutical Science (2.5k citations), Biomaterials (801 citations), Dermatology (533 citations), Virology (185 citations) and Molecular Medicine (147 citations). Abhijit A. Date has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Vandana Patravale, Mangal S. Nagarsenker, Rishikesh M. Kulkarni, Justin Hanes, Medha Joshi, Laura M. Ensign, Neha Desai, Rahul Dixit, Ketan P. Shah and Christopher J. Destache. Their work appears in journals such as Journal of Controlled Release, AAPS PharmSciTech, International Journal of Pharmaceutics, Assay and Drug Development Technologies and ACS Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact